Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians and horse owners one of the most comprehensive product lines in the equine industry. Backed by more than 70 years of innovation, the equine vaccine portfolio is known for its quality and safety, featuring the new line of Prestige® vaccines with updated influenza strains. Its pharmaceutical line is trusted by veterinarians and horse owners to help manage pain and support performance, headlined by Panacur® (fenbendazole), Banamine® (flunixin meglumine), Regu-Mate® (altrenogest) and Protazil® (1.56% diclazuril). For more information, visit www.merck-animal-health-equine.com.
Since 2008, Merck Animal Health has partnered with the American Association of Equine Practitioners to help care for horses in rescue and retirement facilities across the country through the Unwanted Horse Veterinary Relief Campaign (UHVRC). Today, the program has grown to an impact of more than $1 million dollars and more than 28,000 doses of vaccine donations for horses in need. For more information, visit www.UHVRC.org.